Accendra Health Inc (ACH) SEC filings

ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value

$0.15+0.00 (+0.55%)

Close on Nov 12, 2026Market cap $11.23MP/E –Yield –

SEC filings

40 of Accendra Health's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Nov 6, 2026	SEC EDGAR
Current report	8-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Oct 29, 2026	Nov 3, 2026	SEC EDGAR
Current report	8-K	Oct 29, 2026	Nov 2, 2026	SEC EDGAR
Current report	8-K	Oct 27, 2026	Oct 30, 2026	SEC EDGAR
Proxy statement	DEF 14A	Dec 1, 2026	Oct 29, 2026	SEC EDGAR
Current report	8-K	Oct 6, 2026	Oct 9, 2026	SEC EDGAR
Current report	8-K	Sep 16, 2026	Sep 17, 2026	SEC EDGAR
Current report	8-K	Aug 17, 2026	Aug 17, 2026	SEC EDGAR
Current report	8-K	Aug 9, 2026	Aug 10, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 10, 2026	SEC EDGAR
Current report	8-K	Aug 10, 2026	Aug 10, 2026	SEC EDGAR
Current report	8-K	Aug 10, 2026	Aug 10, 2026	SEC EDGAR
Current report	8-K	Jun 23, 2026	Jun 25, 2026	SEC EDGAR
Current report	8-K	Jun 9, 2026	Jun 15, 2026	SEC EDGAR
Current report	8-K	May 22, 2026	May 22, 2026	SEC EDGAR
Current report	8-K	May 14, 2026	May 15, 2026	SEC EDGAR
Current report	8-K	May 11, 2026	May 11, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 11, 2026	SEC EDGAR
Current report	8-K	May 11, 2026	May 11, 2026	SEC EDGAR
Proxy statement	DEF 14A	May 14, 2026	Apr 2, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Feb 20, 2026	SEC EDGAR
Current report	8-K	Feb 19, 2026	Feb 19, 2026	SEC EDGAR
Current report	8-K	Dec 24, 2025	Dec 31, 2025	SEC EDGAR
Current report	8-K	Dec 16, 2025	Dec 18, 2025	SEC EDGAR
Current report	8-K	Dec 4, 2025	Dec 8, 2025	SEC EDGAR
Current report	8-K	Dec 2, 2025	Dec 2, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Oct 31, 2025	SEC EDGAR
Current report	8-K	Oct 30, 2025	Oct 30, 2025	SEC EDGAR
Current report	8-K	Oct 7, 2025	Oct 7, 2025	SEC EDGAR
Current report	8-K	Sep 15, 2025	Sep 19, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 11, 2025	SEC EDGAR
Current report	8-K	Aug 11, 2025	Aug 11, 2025	SEC EDGAR
Current report	8-K	Jun 5, 2025	Jun 6, 2025	SEC EDGAR
Current report	8-K	Jun 5, 2025	Jun 5, 2025	SEC EDGAR
Current report	8-K	May 15, 2025	May 16, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 8, 2025	SEC EDGAR
Current report	8-K	May 8, 2025	May 8, 2025	SEC EDGAR
Current report	8-K	Apr 4, 2025	Apr 4, 2025	SEC EDGAR
Proxy statement	DEF 14A	May 15, 2025	Apr 4, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Accendra Health's annual and quarterly filings with the SEC
Per-share figures adjusted for the 3-for-2 split on Apr 1, 2010
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ACH.

Compare: ACH vs HSIC · ACH vs PLUS · ACH vs AHCO · ACH vs CNXN · ACH vs SCSC

Revenue growth-7.1% · median 13.1%

Gross margin44.1% · median 18.6%

Operating margin0.2% · median 4.1%

Net margin-6.7% · median 3.0%

Company	Revenue	Growth
HSIC	$13.60B	+6.5%
AHCO	$3.58B	+20.7%
SCSC	$3.45B	+14.8%
CNXN	$3.15B	+9.5%
ACH	$2.55B	-7.1%
PLUS	$2.51B	+13.1%

Company

Next earnings (est.): Feb 18, 2027, after close
Exchange: NYSE
Industry: Wholesale-Medical, Dental & Hospital Equipment & Supplies
Fiscal year ends: December 31
Employees: 6,500
Held by institutions: 81.1%
Auditor: KPMG, LLP
SEC CIK: 75252

Advertisement
300 × 250

See a number that looks wrong?